No Cover Image

Journal article 509 views 23 downloads

Synthesis and In Vitro Antimicrobial SAR of Benzyl and Phenyl Guanidine and Aminoguanidine Hydrazone Derivatives

Wolfgang Dohle, Xiangdong Su, Yamni Nigam, Ed Dudley, Barry V. L. Potter Orcid Logo

Molecules, Volume: 28, Issue: 1, Start page: 5

Swansea University Authors: Yamni Nigam, Ed Dudley

  • 62274_VoR.pdf

    PDF | Version of Record

    © 2022 by the authors. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license

    Download (5.28MB)

Abstract

A series of benzyl, phenyl guanidine, and aminoguandine hydrazone derivatives was designed and in vitro antibacterial activities against two different bacterial strains (Staphylococcus aureus and Escherichia coli) were determined. Several compounds showed potent inhibitory activity against the bacte...

Full description

Published in: Molecules
ISSN: 1420-3049
Published: MDPI AG 2022
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa62274
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract: A series of benzyl, phenyl guanidine, and aminoguandine hydrazone derivatives was designed and in vitro antibacterial activities against two different bacterial strains (Staphylococcus aureus and Escherichia coli) were determined. Several compounds showed potent inhibitory activity against the bacterial strains evaluated, with minimal inhibitory concentration (MIC) values in the low µg/mL range. Of all guanidine derivatives, 3-[2-chloro-3-(trifluoromethyl)]-benzyloxy derivative 9m showed the best potency with MICs of 0.5 µg/mL (S. aureus) and 1 µg/mL (E. coli), respectively. Several aminoguanidine hydrazone derivatives also showed good overall activity. Compounds 10a, 10j, and 10r–s displayed MICs of 4 µg/mL against both S. aureus and E. coli. In the aminoguanidine hydrazone series, 3-(4-trifluoromethyl)-benzyloxy derivative 10d showed the best potency against S. aureus (MIC 1 µg/mL) but was far less active against E. coli (MIC 16 µg/mL). Compound 9m and the para-substituted derivative 9v also showed promising results against two strains of methicillin-resistant Staphylococcus aureus (MRSA). These results provide new and potent structural leads for further antibiotic optimisation strategies.
Keywords: benzyl guanidine; benzyl aminoguanidine hydrazone; guanylation; antimicrobial activity; methicillin-resistant Staphylococcus aureus (MRSA)
College: Faculty of Medicine, Health and Life Sciences
Funders: We acknowledge provision of financial support from Research & Innovation, Swansea University, UK.
Issue: 1
Start Page: 5